Cargando…
Factors affecting low fetal fraction in fetal screening with cell-free DNA in pregnant women: a systematic review and meta-analysis
BACKGROUND: Cell-Free DNA (cfDNA) is a non-invasive perinatal test (NIPT) used to assess fetal anomalies. The ability to detect fetal chromosomal aneuploidies is directly related to a sample’s fetal to total DNA fraction, known as the fetal fraction (FF). The minimum FF is considered 4%, and the tes...
Autores principales: | Mousavi, Sanaz, Shokri, Ziba, Bastani, Parvin, Ghojazadeh, Morteza, Riahifar, Sevda, Nateghian, Hooman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733315/ https://www.ncbi.nlm.nih.gov/pubmed/36482322 http://dx.doi.org/10.1186/s12884-022-05224-7 |
Ejemplares similares
-
The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy
por: Brar, Herb, et al.
Publicado: (2013) -
Evaluation of The Relationship between Cell-Free DNA Fetal
Fraction of The Circulatory System and Fetal and Maternal
Pregnancy Prognosis: A Prospective Study
por: Rezaie Keikhaie, Khadije, et al.
Publicado: (2023) -
Factors Affecting the Fetal Fraction in Noninvasive Prenatal Screening: A Review
por: Deng, Cechuan, et al.
Publicado: (2022) -
Maternal and fetal factors influencing fetal fraction: A retrospective analysis of 153,306 pregnant women undergoing noninvasive prenatal screening
por: Deng, Cechuan, et al.
Publicado: (2023) -
The interaction effect of aerobic exercise and vitamin D supplementation on inflammatory factors, anti-inflammatory proteins, and lung function in male smokers: a randomized controlled trial
por: Nikniaz, Leila, et al.
Publicado: (2021)